SPRY1 and central nervous system cancer: Furthermore, the overall survival of adult glioma patients with high SPRY1 levels is strongly reduced in the Kawaguchi datasets (Figure 4A), whereas there is no difference in the overall survival of pediatric glioma patients with high SPRY1 levels in the Paugh datasets (Figure 4B).